13.76
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
35.61%
58.92
|
43.45 | 34.98 | 27.40 | 27.78 |
| Operating Income/Loss |
35.61%
-58.92
|
-43.45 | -34.98 | -27.40 | -27.78 |
| Nonoperating Income/Loss |
2.36%
3.166
|
3.093 | 3.105 | 2.226 | -4.356 |
| Income/Loss From Continuing Operations Before Tax |
38.16%
-55.75
|
-40.35 | -31.87 | -25.18 | -32.13 |
| Income Tax Expense/Benefit |
6.25%
0.015
|
0.016 | 0.058 | - | - |
| Net Income/Loss |
38.14%
-55.77
|
-40.37 | -31.93 | -25.18 | -32.13 |
| Basic Average Shares |
5.67%
61.05
|
57.78 | 7.5434 | 39.58 | 28.43 |
| Diluted Average Shares |
5.67%
61.05
|
57.78 | 7.5434 | 39.58 | 28.43 |
| Basic Earnings Per Share |
33.33%
-0.76
|
-0.57 | -0.11 | -0.48 | -0.86 |
| Diluted Earnings Per Share |
33.33%
-0.76
|
-0.57 | -0.11 | -0.48 | -0.86 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):